TGFβ features an autocrine loop via its downstream targets Sox4, Oct4, and Sox2, and disruption of the TGFβ pathway would hinder the progression of glioma CSCs (Ikushima et al., 2009). The gene discussed is TGFB1; the disease is central nervous system cancer.